Premium
Neonatal adiposity increases with rising cord blood IGF ‐1 levels
Author(s) -
Kadakia Rachel,
Ma Madeleine,
Josefson Jami L.
Publication year - 2016
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.13057
Subject(s) - cord blood , medicine , gestational age , endocrinology , leptin , birth weight , pregnancy , anthropometry , obesity , umbilical cord , biology , immunology , genetics
Objective Infants with higher adiposity at birth may be at greater risk of developing obesity later in life. IGF ‐1 is important for intrauterine growth and may be a useful early life marker of adiposity, and thus later obesity risk. The aim of this study was to determine the relationship between cord blood IGF ‐1, neonatal anthropometrics and markers of neonatal adiposity. Design, Patients and Measurements A cross‐sectional study design was utilized to study a multiethnic cohort of full‐term neonates born to healthy mothers with normal glucose tolerance at a large university hospital. Neonatal cord blood was collected after birth and assayed for IGF ‐1, leptin and C‐peptide. Neonatal body composition was measured between 24 and 72 h of life using the method of air displacement plethysmography. Results Cord blood IGF ‐1 was positively and significantly associated with markers of neonatal adiposity in models adjusted for maternal age at delivery, race, maternal prepregnancy BMI , gestational age at delivery and neonatal sex: birthweight (r = 0·62, P < 0·001), leptin (r = 0·33, P = 0·018), fat mass (r = 0·52, P < 0·001) and percent body fat (r = 0·51, P < 0·001). Cord blood IGF ‐1 was not associated with cord blood C‐peptide. Conclusions Cord blood IGF ‐1 is strongly associated with all measures of neonatal adiposity suggesting that IGF ‐1 may be an important contributor to in utero neonatal fat accumulation.